Literature DB >> 571671

Hypertrophic cardiomyopathy: a discussion of nomenclature.

B J Maron, S E Epstein.   

Abstract

Entities:  

Mesh：

Year:  1979        PMID： 571671     DOI： 10.1016/0002-9149(79)90160-7

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  41 in total

1.  The electrocardiogram as a diagnostic tool for hypertrophic cardiomyopathy: revisited.

Authors:  B J Maron
Journal:  Ann Noninvasive Electrocardiol       Date:  2001-10       Impact factor: 1.468

2.  Stress-induced changes in subendocardial tissue texture in hypertrophic cardiomyopathy: an echocardiographic videodensitometric study.

Authors:  A Pingitore; E Picano; M Paterni; M Passera
Journal:  Int J Cardiovasc Imaging       Date:  2001-08       Impact factor: 2.357

3.  Hemodynamic effects of isometric exercise in hypertrophic cardiomyopathy: comparison with normal subjects.

Authors:  Quirino Ciampi; Sandro Betocchi; Anna Violante; Raffaella Lombardi; Maria Angela Losi; Giovanni Storto; Fiore Manganelli; Carlo Gabriele Tocchetti; Mariano Aversa; Elpidio Pezzella; Filippo Finizio; Alberto Cuocolo; Massimo Chiariello
Journal:  J Nucl Cardiol       Date:  2003 Mar-Apr       Impact factor: 5.952

Review 4.  Problems in diagnosis and management of hypertrophic cardiomyopathy.

Authors:  O Odemuyiwa; W J McKenna
Journal:  Postgrad Med J       Date:  1991-08       Impact factor: 2.401

5.  Diastolic flow velocity pattern of the left anterior descending coronary artery in hypertrophied heart, with special reference to the difference between hypertrophic cardiomyopathy and hypertensive left ventricular hypertrophy.

Authors:  Nobuo Fukuda; Yamato Fukuda; Satofumi Morishita; Koichi Sakabe; Hisanori Shinohara; Yoshiyuki Tamura
Journal:  J Echocardiogr       Date:  2010-01-13

6.  Pneumothorax complicating hypertrophic cardiomyopathy.

Authors:  H Singh
Journal:  Can J Anaesth       Date:  1996-04       Impact factor: 5.063

7.  Aortic regurgitation associated with hypertrophic cardiomyopathy: a colour Doppler echocardiographic study.

Authors:  T Shiota; T Sakamoto; K Takenaka; K Amano; Y Hada; I Hasegawa; J Suzuki; H Takahashi; T Sugimoto
Journal:  Br Heart J       Date:  1989-09

8.  Decreased exercise capacity and sleep-disordered breathing in patients with hypertrophic cardiomyopathy.

Authors:  Tomas Konecny; Jeffrey B Geske; Ondrej Ludka; Marek Orban; Peter A Brady; Muaz M Abudiab; Felipe N Albuquerque; Alexander Placek; Tomas Kara; Karine R Sahakyan; Bernard J Gersh; A Jamil Tajik; Thomas G Allison; Steve R Ommen; Virend K Somers
Journal:  Chest       Date:  2015-06       Impact factor: 9.410

9.  The effects of candesartan on left ventricular hypertrophy and function in nonobstructive hypertrophic cardiomyopathy: a pilot, randomized study.

Authors:  Martin Penicka; Pavel Gregor; Roman Kerekes; Dan Marek; Karol Curila; Jiri Krupicka
Journal:  J Mol Diagn       Date:  2008-12-12       Impact factor: 5.568

10.  QT dispersion and left ventricular morphology in patients with hypertrophic cardiomyopathy.

Authors:  K Sakata; M Shimizu; H Ino; M Yamaguchi; H Terai; K Hayashi; M Kiyama; T Hayashi; M Inoue; H Mabuchi
Journal:  Heart       Date:  2003-08       Impact factor: 5.994
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.